Table of Contents
ISRN Medicinal Chemistry
Volume 2013 (2013), Article ID 107840, 8 pages
http://dx.doi.org/10.1155/2013/107840
Research Article

Sulfonamide Based β-Carbonic Anhydrase Inhibitors: 2D QSAR Study

Department of Chemistry, PDEA’s S. G. R. S. College of Pharmacy, University of Pune, Pune 412203, India

Received 14 August 2013; Accepted 10 October 2013

Academic Editors: A. Afantitis, R. Giridhar, and S. Rivara

Copyright © 2013 Meenakshi N. Deodhar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. T. Supuran, “Carbonic anhydrases: novel therapeutic applications for inhibitors and activators,” Nature Reviews Drug Discovery, vol. 7, no. 2, pp. 168–181, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Scozzafava, A. Mastrolorenzo, and C. T. Supuran, “Carbonic anhydrase inhibitors and activators and their use in therapy,” Expert Opinion on Therapeutic Patents, vol. 16, no. 12, pp. 1627–1664, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. C. T. Supuran, A. Scozzafava, and A. Casini, “Carbonic anhydrase inhibitors,” Medicinal Research Reviews, vol. 23, no. 2, pp. 146–189, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Xu, L. Feng, P. D. Jeffrey, Y. Shi, and F. M. M. Morel, “Structure and metal exchange in the cadmium carbonic anhydrase of marine diatoms,” Nature, vol. 452, no. 7183, pp. 56–61, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Stams and D. W. Christianson, “X-ray crystallographic studies of mammalian carbonic anhydrase isozymes,” in The Carbonic Anhydrases—New Horizons, W. R. Chegwidden, N. D. Carter, and Y. H. Edwards, Eds., pp. 159–174, Birkhäuser, Basel, Switzerland, 2000. View at Google Scholar
  6. A. Thiry, J.-M. Dogné, B. Masereel, and C. T. Supuran, “Targeting tumor-associated carbonic anhydrase IX in cancer therapy,” Trends in Pharmacological Sciences, vol. 27, no. 11, pp. 566–573, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. C. T. Supuran, A. Casini, A. Mastrolorenzo, and A. Scozzafava, “COX-2 selective inhibitors, carbonic anhydrase inhibition and anticancer properties of sulfonamides belonging to this class of pharmacological agents,” Mini-Reviews in Medicinal Chemistry, vol. 4, no. 6, pp. 625–632, 2004. View at Google Scholar · View at Scopus
  8. C. T. Supuran, “Carbonic anhydrase inhibitors in the treatment and prophylaxis of obesity,” Expert Opinion on Therapeutic Patents, vol. 13, no. 10, pp. 1545–1550, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. C. T. Supuran, A. Scozzafava, F. Mincione et al., “Carbonic anhydrase inhibitors. Part 60. The topical intraocular pressure-lowering properties of metal complexes of a heterocyclic sulfonamide: influence of the metal ion upon biological activity,” European Journal of Medicinal Chemistry, vol. 34, no. 7-8, pp. 585–595, 1999. View at Google Scholar · View at Scopus
  10. M. S. Kyllönen, S. Parkkila, H. Rajaniemi et al., “Localization of carbonic anhydrase XII to the basolateral membrane of H+-secreting cells of mouse and rat kidney,” Journal of Histochemistry and Cytochemistry, vol. 51, no. 9, pp. 1217–1224, 2003. View at Google Scholar · View at Scopus
  11. S. Elleuche and S. Pöggeler, “Evolution of carbonic anhydrases in fungi,” Current Genetics, vol. 55, no. 2, pp. 211–222, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Eriksson, J. Karlsson, Z. Ramazanov, P. Gardeström, and G. Samuelsson, “Discovery of an algal mitochondrial carbonic anhydrase: molecular cloning and characterization of a low-CO2-induced polypeptide in Chlamydomonas reinhardtii,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 21, pp. 12031–12034, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. A. K. C. So and G. S. Espie, “Cloning, characterization and expression of carbonic anhydrase from the Cyanobacterium synechocystis PCC6803,” Plant Molecular Biology, vol. 37, no. 2, pp. 205–215, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Amoroso, L. Morell-Avrahov, D. Müller, K. Klug, and D. Sültemeyer, “The gene NCE103 (YNL036w) from Saccharomyces cerevisiae encodes a functional carbonic anhydrase and its transcription is regulated by the concentration of inorganic carbon in the medium,” Molecular Microbiology, vol. 56, no. 2, pp. 549–558, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. M. B. Guilloton, J. J. Korte, A. F. Lamblin, J. A. Fuchs, and P. M. Anderson, “Carbonic anhydrase in Escherichia coli—a product of the cyn operon,” Journal of Biological Chemistry, vol. 267, no. 6, pp. 3731–3734, 1992. View at Google Scholar · View at Scopus
  16. K. S. Smith, C. Jakubzick, T. S. Whittam, and J. G. Ferry, “Carbonic anhydrase is an ancient enzyme widespread in prokaryotes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 26, pp. 15184–15189, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. R. S. Rowlett, “Structure and catalytic mechanism of the β-carbonic anhydrases,” Biochimica et Biophysica Acta, vol. 1804, no. 2, pp. 362–373, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. M. R. Sawaya, G. C. Cannon, S. Heinhorst et al., “The structure of β-carbonic anhydrase from the carboxysomal shell reveals a distinct subclass with one active site for the price of two,” Journal of Biological Chemistry, vol. 281, no. 11, pp. 7546–7555, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Klengel, W.-J. Liang, J. Chaloupka et al., “Fungal adenylyl cyclase integrates CO2 sensing with cAMP signaling and virulence,” Current Biology, vol. 15, no. 22, pp. 2021–2026, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Hansch, In Exploring QSAR: Fundamentals and Applications, in Chemistry and Biology, American Society, Washington, DC, USA, 1995.
  21. F. Pacchiano, F. Carta, D. Vullo, A. Scozzafava, and C. T. Supuran, “Inhibition of β-carbonic anhydrases with ureido-substituted benzenesulfonamides,” Bioorganic and Medicinal Chemistry Letters, vol. 21, no. 1, pp. 102–105, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. Ö. Güzel, A. Maresca, R. A. Hall et al., “Carbonic anhydrase inhibitors. The β-carbonic anhydrases from the fungal pathogens Cryptococcus neoformans and Candida albicans are strongly inhibited by substituted-phenyl-1H-indole-5-sulfonamides,” Bioorganic and Medicinal Chemistry Letters, vol. 20, no. 8, pp. 2508–2511, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. I. Nishimori, T. Minakuchi, T. Kohsaki et al., “Carbonic anhydrase inhibitors: the β-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors,” Bioorganic and Medicinal Chemistry Letters, vol. 17, no. 13, pp. 3585–3594, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Bertucci, A. Innocenti, A. Scozzafava, S. Tambutté, D. Zoccola, and C. T. Supuran, “Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata,” Bioorganic and Medicinal Chemistry Letters, vol. 21, no. 2, pp. 710–714, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. S. M. Monti, A. Maresca, F. Viparelli et al., “Dithiocarbamates are strong inhibitors of the beta-class fungal carbonic anhydrases from Cryptococcus neoformans, Candida albicans and Candida glabrata,” Bioorganic and Medicinal Chemistry Letters, vol. 22, no. 2, pp. 859–862, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Rami, A. Innocenti, J.-L. Montero, A. Scozzafava, J.-Y. Winum, and C. T. Supuran, “Synthesis of rhodamine B-benzenesulfonamide conjugates and their inhibitory activity against human α- and bacterial/fungal β-carbonic anhydrases,” Bioorganic and Medicinal Chemistry Letters, vol. 21, no. 18, pp. 5210–5213, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Isik, F. Kockar, M. Aydin et al., “Carbonic anhydrase inhibitors: inhibition of the β-class enzyme from the yeast Saccharomyces cerevisiae with sulfonamides and sulfamates,” Bioorganic and Medicinal Chemistry, vol. 17, no. 3, pp. 1158–1163, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. I. Nishimori, T. Minakuchi, D. Vullo, A. Scozzafava, and C. T. Supuran, “Inhibition studies of the β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates,” Bioorganic and Medicinal Chemistry, vol. 19, no. 16, pp. 5023–5030, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Innocenti, R. A. Hall, C. Schlicker et al., “Carbonic anhydrase inhibitors. Inhibition and homology modeling studies of the fungal β-carbonic anhydrase from Candida albicans with sulfonamides,” Bioorganic and Medicinal Chemistry, vol. 17, no. 13, pp. 4503–4509, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. Ö. Güzel, A. Maresca, A. Scozzafava, A. Salman, A. T. Balaban, and C. T. Supuran, “Discovery of low nanomolar and subnanomolar inhibitors of the mycobacterial β-carbonic anhydrases Rv1284 and Rv3273,” Journal of Medicinal Chemistry, vol. 52, no. 13, pp. 4063–4067, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Innocenti, R. A. Hall, C. Schlicker, F. A. Mühlschlegel, and C. T. Supuran, “Carbonic anhydrase inhibitors. Inhibition of the β-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with aliphatic and aromatic carboxylates,” Bioorganic and Medicinal Chemistry, vol. 17, no. 7, pp. 2654–2657, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Pothen, V. Singh, S. Kumar, and M. Tiwari, “Structural optimization of new class of selective carbonic anhydrase inhibitors: QSAR approach,” Indian Journal of Chemistry B, vol. 49, no. 2, pp. 224–233, 2010. View at Google Scholar · View at Scopus
  33. V-life MDS3.5 Vlife science technologies pvt. Ltd, 1 akshay residency, plot 50 anand park, aundh pune 411007.
  34. “Chemdraw ultra 8.0 and Chem3D ultra,” Tech. Rep., Cambridge Soft Corporation, Cambridge, Mass, USA, http://www.cambridgesoft.com.
  35. R. G. Khalifah, “The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C,” Journal of Biological Chemistry, vol. 246, no. 8, pp. 2561–2573, 1971. View at Google Scholar · View at Scopus
  36. R. Veerasamy, H. Rajak, A. Jain et al., “Validation of QSAR models-strategies and importance,” International Journal of Drug Design & Discovery, vol. 3, pp. 511–519, 2011. View at Google Scholar
  37. A. Golbraikh and A. Tropsha, “Beware of q2!,” Journal of Molecular Graphics and Modelling, vol. 20, no. 4, pp. 269–276, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Tropsha, P. Gramatica, and V. K. Gombar, “The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSPR models,” QSAR and Combinatorial Science, vol. 22, no. 1, pp. 69–77, 2003. View at Google Scholar · View at Scopus
  39. H. Kubinyl, “Variable selection in QSAR studies. I. An evolutionary algorithm,” Quantitative Structure-Activity Relationships, vol. 13, no. 3, pp. 285–294, 1994. View at Google Scholar · View at Scopus
  40. R. P. Verma and C. Hansch, “An approach toward the problem of outliers in QSAR,” Bioorganic and Medicinal Chemistry, vol. 13, no. 15, pp. 4597–4621, 2005. View at Publisher · View at Google Scholar · View at Scopus